Neuraxpharm Group makes a step forward by rebranding its subsidiary also in Italy
Today, October 10th, we are celebrating World Mental Health Day, with the overall objective of raising awareness of mental health issues around the world and mobilising efforts in support of mental health.
Neuraxpharm will exhibit at the upcoming CPhI WW in Madrid, from October 9th to 11th
Neuraxpharm launches its new name to support its strategic vision
NuPharm Group, a leading European specialty pharma company focussed on the treatment of central nervous system (CNS) disorders, has today announced that Dr. Jörg-Thomas Dierks has been appointed Chief Executive Officer (CEO) effective immediately. Jörg is replacing Stephan Walz, who has decided to step down in order to pursue other activities.